FDA’s new National Priority Vouchers could grow the addiction medicine pipeline
Progress towards CASPR's goal to create a PRV for addiction medicine| Recursive Adaptation - Addiction Medicine and Policy
Progress towards CASPR's goal to create a PRV for addiction medicine| Recursive Adaptation - Addiction Medicine and Policy
Gallup has a new poll showing a big drop in Americans who say they drink alcohol, down to a record low 54%.| recursiveadaptation.com
Escaping the caustic drug war debates through better medications for substance use disorder.| recursiveadaptation.com
The first real-world pilot program of GLP-1s for addiction treatment.| recursiveadaptation.com
If you are going to CPDD, please reach out!| recursiveadaptation.com
Solving addiction is achievable and has a higher ROI than nearly any charitable initiative.| recursiveadaptation.com
15 patients are already receiving semaglutide as part of their treatment program.| recursiveadaptation.com
Documentary opportunity, opioids + stimulants, and more news| recursiveadaptation.com
A shopping addiction and alcohol addiction disappeared with semaglutide.| Recursive Adaptation - Addiction Medicine and Policy
Addiction news and updates| Recursive Adaptation - Addiction Medicine and Policy
5 stories from patients.| Recursive Adaptation - Addiction Medicine and Policy
Trials and programs that CASPR is running or making possible.| Recursive Adaptation - Addiction Medicine and Policy
Novel program will integrate GLP-1 receptor agonist (GLP-1RA) therapy into residential treatment programs for individuals in early recovery| Recursive Adaptation - Addiction Medicine and Policy
Be in touch if you would like to join.| Recursive Adaptation - Addiction Medicine and Policy
Has the FDA already updated AUD qualified endpoints but can't say so yet?| Recursive Adaptation - Addiction Medicine and Policy
Sue Grigson's trial is looking at semaglutide for OUD-- and they urgently need support to add more patients.| Recursive Adaptation - Addiction Medicine and Policy
New RCT shows Tylenol plus Ibuprofen works better than Vicodin| Recursive Adaptation - Addiction Medicine and Policy
A support plus GLP-1 study that confronts the cycle of addiction and incarceration amongst women.| Recursive Adaptation - Addiction Medicine and Policy
And will patients turn on Trump and RFK as hundreds of thousands lose access to GLP-1s?| recursiveadaptation.com
Powerful findings in Christian Hendershot's RCT w/ 48 non-treatment seekers and relatively low doses of semaglutide.| recursiveadaptation.com
From more than a dozen drinks a day to zero overnight.| recursiveadaptation.com
“I’m now offering GLP-1s to nearly all my substance use disorder patients.”| recursiveadaptation.com
A unique opportunity for a breakthrough in medicine and public health| recursiveadaptation.com
We've been very, very, very busy!| recursiveadaptation.com
How a Fortune 50 VP controlled his "20 pack-year" and a 5- to 6-drink a night habits.| recursiveadaptation.com
"Everything changed when I was prescribed tirzepatide in 2019."| recursiveadaptation.com
from CASPR and Institute for Progress (IFP)| recursiveadaptation.com
The science, medicine, patient experiences, provider experiences, policy, and more.| recursiveadaptation.com
One patient describes how getting on Mounjaro gave her her freedom back.| recursiveadaptation.com
Tirzepatide helped a patient with chronic back pain overcome a cycle of opiate and alcohol overuse.| recursiveadaptation.com
A patient describes how Ozempic and Mounjaro ended her drinking after all else had failed.| recursiveadaptation.com
Why is the disease that causes more deaths than any other still considered a small drug market?| recursiveadaptation.com
Better, more appealing medications for drug use disorders can drive population-level improvements.| recursiveadaptation.com
There’s a strong non-addictive, opioid-replacing painkiller coming soon, but most patients won't be able to get it.| recursiveadaptation.com
But access will be a major obstacle without a policy intervention.| recursiveadaptation.com
Why does the United States put so few resources into developing new medical treatments for drug abuse when the ongoing financial, social, and medical costs of addiction are so shockingly high?| recursiveadaptation.com
GLP-1s are showing dramatic results in reducing addictive drive while providing holistic mental health benefits to patients.| recursiveadaptation.com
Dr.| recursiveadaptation.com
